The pharmaceutical industry is facing an increasing number of challenges on a global stage. Asia Pacific - in particular China and India - is considered the future growth engine for the industry.

Whilst many pharmaceutical companies focus on expanding their existing position and enhancing productivity, others, particularly biotechnology and specialty pharmaceutical companies, have yet to unlock the potential of this fragmented and complex region.

PharmaLink are specialists in developing tailored solutions and commercial models which optimise revenues for franchises and products as well as reducing the risk of market entry for new players into the Asia Pacific Region.

Our competitive edge is rooted in the total focus on our core business of commercialising pharmaceutical products, along with the ability to invest in clinical and market development.

At PharmaLink, we are proud of our unique combination of excellent global practices and a deep understanding of the Asia Pacific marketplace. Our affiliation with Quintiles and Innovex ensures our awareness of current developments in the global arena.

We are committed to drive our leadership position in the industry by investing in skills development and capabilities through our accredited PharmaLink Academies, Regional Regulatory Affairs services and Marketing Intelligence services.

With that, we hope to introduce to you our services in greater detail and provide the winning difference to your businesses.